I'm a medical student at Indiana University passionate about psychiatry, preventive medicine, and contributing to accessible, sustainable innovation in healthcare.
I'm passionate about psychiatry, neuroscience, and the engineering of better mental healthcare. My research interests include interventional psychiatry, addiction medicine, and innovative, scalable approaches to mental health.
At IU's Neural Systems Laboratory, I'm building quantitative models of alcohol tolerance and cognitive-behavioral effects, work foundational to understanding addiction as a disease of individual variation. Previously at Stanford, I studied Body Dysmorphic Disorder and psychiatric comorbidities in surgical populations, and I've published on opioid prescribing patterns with direct relevance to addiction psychiatry.
While in college, I started Theramate with a Johns Hopkins psychiatrist to create a mobile app to help providers monitor patients with mood and substance use disorders and reduce readmissions for dual-diagnosis patients. It was my first real lesson in what psychiatry needs: not just better drugs, but better systems.
I also co-founded and exited surgical instrument startup Benegraft (acquired by Osteopore, 2021), served on the venture investment diligence team at Boomerang Ventures with a psychiatry/neurology focus, and teach design thinking as faculty at Purdue's BME program.
Investigating how alcohol exposure drives acute tolerance through integrated pharmacokinetic data, subjective response measures, and neuroadaptation models. Building quantitative mathematical models of individual and group differences in alcohol sensitivity by drinking phenotype.
Studied the relationship between BDD screening, patient expectations, and cosmetic outcomes. Contributed to research on psychological risk stratification and psychiatric comorbidities in surgical populations. Co-authored publication in Aesthetic Surgery Journal.
Analyzed persistent opioid use following surgery, identifying behavioral and clinical risk factors for chronic opioid exposure with direct relevance to addiction psychiatry. Published systematic review in Otolaryngology–Head and Neck Surgery.
Clinical efficacy and implementation considerations of transcranial direct current stimulation for MDD — reviewing evidence for a novel, scalable approach to treatment-resistant depression.
Founded with a Johns Hopkins psychiatrist to build EMR-integrated software allowing providers to monitor patients with mood and substance use disorders, reducing readmissions for dual-diagnosis patients. Only undergraduate admitted to the Hopkins School of Medicine Health Technology Accelerator.
Spun out of Johns Hopkins BME. Led a team of seven to commercialize the first surgical instrument to simplify cartilage graft preparation for rhinoplasty. Raised seed funding, authored IP claims, and led acquisition by Osteopore — debuted at AAO-HNSF 2022.
Conducting due diligence and stakeholder interviews for seed-to-Series A investments in connected healthcare. Focus: digital therapeutics, neurology, VR in pain management, and mental health technology.
Performed root cause analysis on FDA MAUDE-flagged issues in Auris's telesurgical platform. Devised first software workflows for clinical data retrieval and analysis using Qubole on Amazon S3.
Stories about innovators reshaping medicine and leadership. Episodes include Reality Distortion: AI Slop and the Modern Battle for Truth and How a Doctor Brought the da Vinci System to the OR. Listen on Spotify →
State Delegate and Medical Student Representative, Indiana State Medical Association. Authored or co-authored the following resolutions and legislation:
A first-person account of volunteering in the Johns Hopkins pediatric ED — on the gap between clinical care and community need.
A deep technical and societal exploration of autonomous vehicles — from sensor physics to urban planning implications.
Indianapolis, April 2026.
Here are some books and other resources I love.